Skip to main content
Log in

Lidocaine treatment of neonatal convulsions, a therapeutic dilemma

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Three infants with neonatal convulsions were given lidocaine infusions for three days, three weeks and three months, respectively, and the plasma concentrations of lidocaine and its metabolites were analyzed by HPLC.

After a prolonged infusion there was considerable accumulation of the metabolites.

This may account for the difficulty of stopping the infusion without relapse of the seizures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bauer LA, Brown T, Gibaldi M, Hudson L, Nelson S, Raisys V, Shea JP (1982) Influence of long-term infusions on lidocaine kinetics. Clin Pharmacol Ther 31: 433–437

    Google Scholar 

  • Blumer J, Strong JM, Atkinson AJ (1973) The convulsant potency of lidocaine and its dealkylated metabolites. J Pharmacol Exp Ther 80: 31–36

    Google Scholar 

  • Cusack B, O'Malley K, Lavan J, Noel J, Kelly JG (1985) Protein binding and disposition of lignocaine in the elderly. Eur J Clin Pharmacol 29: 323–329

    Google Scholar 

  • Cusson J, Nattel N, Matthews C, Talajic M, Lawand S (1985) Age-dependent lidocaine disposition in patients with acute myocardial infarction. Clin Pharmacol Ther 37: 381–386

    Google Scholar 

  • Drayer DE, Lorenzo B, Werns S, Reidenberg MM (1983) Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clin Pharmacol Ther 34: 14–22

    Google Scholar 

  • Eyres RL, Bishop W, Oppenheim RC, Brown TCK (1983) Plasma lignocaine concentrations following topical laryngeal application. Anesth Intensive Care 11: 23–26

    Google Scholar 

  • Gamstorp I (1985) Pediatric neurology. Butterworths, London, pp 108–110

    Google Scholar 

  • Giard MJ, Uden UL, Whitlock DJ, Wastson DM (1983) Seizures induced by oral viscous lidocaine. Clin Pharm 2: 110

    Google Scholar 

  • Kuhnert BR, Knapp DR, Kuhnert PM, Prochaska AL (1979) Maternal, fetal and neonatal metabolism of lidocaine. Clin Pharmacol Ther 26: 213–220

    Google Scholar 

  • Mihaly GW, Moore RG, Thomas J, Triggs EJ, Thomas D (1978) The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine. Eur J Clin Pharmacol 13: 143–152

    Google Scholar 

  • Mofenson HC, Caraccio TR, Miller H, Greensher J (1983) Lidocaine toxicity from topical mucosal application. Clin Pediatr 22: 190–192

    Google Scholar 

  • Philipson EH, Kuhnert BR, Syracuse CD (1984) Maternal, fetal, and neonatal lidocaine levels following local perineal infiltration. Am J Obstet Gynecol 149: 403–407

    Google Scholar 

  • Rothstein P, Dornbusch J, Shaywitz BA (1982) Prolonged seizures associated with the use of viscous lidocaine. J Pediatr 101: 461–463

    Google Scholar 

  • Strong JM, Mayfield DE, Atkinson AJ, Burris BC, Raymon F, Webster LT (1975) Pharmacological activity, metabolism, and pharmacokinetics och glycinexylidide. Clin Pharmacol Ther 17: 184–194

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallin, A., Nergårdh, A. & Hynning, P.Å. Lidocaine treatment of neonatal convulsions, a therapeutic dilemma. Eur J Clin Pharmacol 36, 583–586 (1989). https://doi.org/10.1007/BF00637740

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637740

Key words

Navigation